a public good project by the
Synthesis
Company
of California

© 2026

Samuel A. Wells | doi.page

0 works0 citations0 h-index

Samuel A. Wells

Southern Utah University(US)King's College London(GB)

Publications by Year

Research Areas

Thyroid Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances, Parathyroid Disorders and Treatments, Cancer-related Molecular Pathways, Pituitary Gland Disorders and Treatments

Most-Cited Works

→ Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma(2015)2,340 cited
→ CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2(2001)1,900 cited
→ Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial(2011)1,527 cited
→ Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association(2009)1,351 cited
→ Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC(1993)1,300 cited
→ Biologic and Clinical Perspectives on Thyroid Cancer(2016)972 cited

→ Summary Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism: A Perspective for the 21st Century(2002)

772 cited

→ Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.(1994)597 cited

→ Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer(2010)514 cited

→ Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A(1994)446 cited